Literature DB >> 12093240

Reporting the recruitment process in clinical trials: who are these patients and how did they get there?

Cary P Gross1, Raburn Mallory, Asefeh Heiat, Harlan M Krumholz.   

Abstract

BACKGROUND: A common criticism of randomized, controlled trials (RCTs) is that the enrollment process may be highly selective and those who enroll may not represent persons in the general population. The recruitment process reported in published RCTs has not been systematically evaluated.
OBJECTIVE: To determine whether published RCTs report information about how their study sample was assembled and to describe the proportion of potential study participants who were actually enrolled.
DESIGN: Cross-sectional explicit review of RCTs published in four high-impact medical journals between 1 April 1999 and 1 April 2000. All RCTs involved interventions in humans. MEASUREMENTS: The number of persons who were screened for eligibility, the number who were eligible, and the number who were enrolled in each RCT.
RESULTS: A total of 172 RCTs were reviewed. Ninety (52%) reported the number of persons who were evaluated by the investigators for eligibility, and 74 (43%) reported the number of persons who were actually eligible for participation. Of the studies that reported quantitative recruitment information, the median proportion of screened persons who were eligible for participation was 65% (interquartile range, 41% to 82%) and the median proportion of eligible persons who enrolled was 93% (interquartile range, 79% to 100%). Some trials reportedly enrolled every person screened for eligibility; others screened as many as 68 people for each person finally enrolled.
CONCLUSIONS: Many RCTs published in major medical journals do not provide information about the patient recruitment process. As a result, it is difficult for readers to gauge the extent to which participants may represent a highly selected subgroup.

Entities:  

Mesh:

Year:  2002        PMID: 12093240     DOI: 10.7326/0003-4819-137-1-200207020-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  60 in total

1.  Factors influencing enrollment of African Americans in the Look AHEAD trial.

Authors:  David L Mount; Cralen Davis; Betty Kennedy; Susan Raatz; Kathy Dotson; Tiffany L Gary-Webb; Sheikilya Thomas; Karen C Johnson; Mark A Espeland
Journal:  Clin Trials       Date:  2011-11-07       Impact factor: 2.486

2.  Neglected external validity in reports of randomized trials: the example of hip and knee osteoarthritis.

Authors:  Nizar Ahmad; Isabelle Boutron; David Moher; Isabelle Pitrou; Carine Roy; Philippe Ravaud
Journal:  Arthritis Rheum       Date:  2009-03-15

3.  Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders.

Authors:  Keith Humphreys; Natalya C Maisel; Janet C Blodgett; John W Finney
Journal:  J Stud Alcohol Drugs       Date:  2013-11       Impact factor: 2.582

4.  Clinicians' Guide to Statistics for Medical Practice and Research: Part II.

Authors:  Marie A Krousel-Wood; Richard B Chambers; Paul Muntner
Journal:  Ochsner J       Date:  2007

5.  Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages.

Authors:  Richard L Kravitz; Naihua Duan; Joel Braslow
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

6.  Views of older adults on patient participation in medication-related decision making.

Authors:  Vernee N Belcher; Terri R Fried; Joseph V Agostini; Mary E Tinetti
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

7.  Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes.

Authors:  Mary E Tinetti; Gail J McAvay; Terri R Fried; Heather G Allore; Joanna C Salmon; Joanne M Foody; Luann Bianco; Sandra Ginter; Liana Fraenkel
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

8.  Lessons for successful study enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study.

Authors:  Susan T Crowley; Glenn M Chertow; Joseph Vitale; Theresa O'Connor; Jane Zhang; Roland M H Schein; Devasmita Choudhury; Kevin Finkel; Anitha Vijayan; Emil Paganini; Paul M Palevsky
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 8.237

9.  Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research.

Authors:  Laura B Dunn; Daniel S Kim; Ian E Fellows; Barton W Palmer
Journal:  Schizophr Bull       Date:  2008-02-14       Impact factor: 9.306

10.  A review of reporting of participant recruitment and retention in RCTs in six major journals.

Authors:  Merran Toerien; Sara T Brookes; Chris Metcalfe; Isabel de Salis; Zelda Tomlin; Tim J Peters; Jonathan Sterne; Jenny L Donovan
Journal:  Trials       Date:  2009-07-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.